VAERS Explorer
Back to explore

Report #2839061

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
72 yrs
State
—
Recovered
Not recovered
Vaccinated
Apr 22, 2025
Onset
Apr 22, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK3043838IM

Symptoms (5)

FatigueInjection site bruisingInjection site massInjection site painUrticaria

Symptom narrative

she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area; experienced fatigue; She also experienced pain at injection site along with a large hard lump and bruising at injection site; She also experienced pain at injection site along with a large hard lump and bruising at injection site; She also experienced pain at injection site along with a large hard lump and bruising at injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area), FATIGUE (experienced fatigue), INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site) in a 72-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3043838) for COVID-19 prophylaxis. The patient's past medical history included Skin cancer. Previously administered products included for Product used for unknown indication: Pfizer BioNTech COVID-19 vaccine (she has always taken Pfizer COVID vaccine before). Past adverse reactions to the above products included No adverse effect with Pfizer BioNTech COVID-19 vaccine. On 22-Apr-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On 22-Apr-2025, the patient experienced INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), FATIGUE (experienced fatigue), INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site). On 23-Apr-2025, the patient experienced URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area). At the time of the report, INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area), FATIGUE (experienced fatigue) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site) had not resolved and INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) had resolved. No concomitant medications were reported. It was reported that she was taking Moderna vaccine for the first time and always taken Pfizer vaccine before. On the day of vaccination, patient experienced fatigue and that lasted for 2 days. She also experienced pain at injection site along with a large hard lump and bruising at injection site. It was reported that 2 days after vaccine administration, the pain was gone but the bruising and lump still persist. On 23-Apr-2025, 19 hours after vaccination, she developed a hive (urticaria) on the right foot and on 24-Apr-2025, she also had hives in the middle of gluteal area. It was unknown if the patient experienced any additional symptoms or events. No treatment medications were reported.

Medical history

Medical History/Concurrent Conditions: Skin cancer